These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 24612000)

  • 61. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.
    Moum B; Ekbom A; Vatn MH; Aadland E; Sauar J; Lygren I; Schulz T; Stray N; Fausa O
    Scand J Gastroenterol; 1997 Oct; 32(10):1005-12. PubMed ID: 9361173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
    Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
    World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
    Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
    Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?
    Koek GH; Verleden GM; Evenepoel P; Rutgeerts P
    Respir Med; 2002 Jul; 96(7):530-5. PubMed ID: 12194639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.
    Kovacs M; Muller KE; Arato A; Lakatos PL; Kovacs JB; Varkonyi A; Solyom E; Polgar M; Nemes E; Guthy I; Tokodi I; Toth G; Horvath A; Tarnok A; Tomsits E; Csoszánszky N; Balogh M; Vass N; Bodi P; Dezsofi A; Gardos L; Micskey E; Papp M; Szucs D; Cseh A; Molnar K; Szabo D; Veres G;
    J Crohns Colitis; 2012 Feb; 6(1):86-94. PubMed ID: 22261532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
    Joo M; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
    Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
    Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ex vivo histology-correlated optical coherence tomography in the detection of transmural inflammation in Crohn's disease.
    Shen B; Zuccaro G; Gramlich TL; Gladkova N; Lashner BA; Delaney CP; Connor JT; Remzi FH; Kareta M; Bevins CL; Feldchtein F; Strong SA; Bambrick ML; Trolli P; Fazio VW
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):754-60. PubMed ID: 15354275
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diagnostic problems of histological remission in patients with inflammatory bowel disease].
    Tertychnyi AS; Akhrieva KM; Maev IV; Zayratyants OV; Selivanova LS
    Arkh Patol; 2017; 79(3):3-9. PubMed ID: 28631710
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.
    Yang L; Tang S; Baker SS; Arijs I; Liu W; Alkhouri R; Lan P; Baker RD; Tang Z; Ji G; Rutgeerts P; Vermeire S; Zhu R; Zhu L
    Inflamm Bowel Dis; 2019 Mar; 25(4):722-731. PubMed ID: 30517639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Colon capsule endoscopy is a safe and useful tool to assess disease parameters in patients with ulcerative colitis.
    San Juan-Acosta M; Caunedo-Álvarez A; Argüelles-Arias F; Castro-Laria L; Gómez-Rodríguez B; Romero-Vázquez J; Belda-Cuesta A; Pellicer-Bautista F; Herrerías-Gutiérrez JM
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):894-901. PubMed ID: 24987825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease.
    Yılmaz B; Köklü S; Yüksel O; Arslan S
    World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.
    Ford AC; Moayyedi P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Reinisch W
    Am J Gastroenterol; 2015 May; 110(5):716-24. PubMed ID: 25916225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W; Teng G; Wu T; Tian Y; Wang H
    Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.